阿帕替尼在非小细胞肺癌中的研究进展
梁利军， 蒋晓东 - 肿瘤防治研究, 2018 - zlfzyj.com
… that apatinib monotherapy has well efficacy on advanced NSCLC. Preclinical studies suggest
that apatinib … Clinical response to apatinib monotherapy in advanced non-small cell lung …
that apatinib … Clinical response to apatinib monotherapy in advanced non-small cell lung …
甲磺酸阿帕替尼与多西他赛治疗晚期非小细胞肺癌的疗效比较
王雅婕， 秦博宇， 胡毅 - 解放军医学院学报, 2018 - xuebao.301hospital.com.cn
… efficacy and adverse reactions of mesylate apatinib versus docetaxel for advanced non-small
cell lung cancer … Methods Clinical data about 128 patients with advanced NSCLC admittted …
cell lung cancer … Methods Clinical data about 128 patients with advanced NSCLC admittted …
[HTML][HTML] 免疫检查点抑制剂联合抗血管生成药物治疗肺肉瘤样癌: 1 例病例报告及文献综述
赵倩倩， 王传玺 - Advances in Clinical Medicine, 2023 - hanspub.org
… carcinoma (PSC), characterized by poor differentiation, aggressive progres-sion, and easy
distant metastasis, is a rare type of non-small cell lung cancer (… the efficacy and safety of …
distant metastasis, is a rare type of non-small cell lung cancer (… the efficacy and safety of …
甲磺酸阿帕替尼治疗驱动基因未明的晚期非小细胞肺癌的观察性研究
范少泷， 邹玉环， 房芳， 宋文广， 王毅峰 - 中国医药导刊, 2017 - zgyydk.cn
… the efficacy and safety of apatinib with non-interfered in patients with EGFR gene wild type
or unknown of advanced non-small cell lung cancer(… Methods:All the patients come from our …
or unknown of advanced non-small cell lung cancer(… Methods:All the patients come from our …
甲磺酸阿帕替尼治疗一例肺腺癌脑转移患者的疗效分析
祝金龙， 王红 - Asian Case Reports in Oncology, 2017 - hanspub.org
… than 20%, non-small cell lung cancer accounting for more than … Acid apatinib shows excellent
efficacy and good tolerance … of apatinib mesylate as a fourth-line drug treatment in patients …
efficacy and good tolerance … of apatinib mesylate as a fourth-line drug treatment in patients …
[HTML][HTML] 阿帕替尼用于一线治疗进展后晚期非鳞非小细胞肺癌的疗效和生存分析
王学敏， 张维红， 杜伟娇， 张新伟… - … Journal of Lung Cancer, 2017 - ncbi.nlm.nih.gov
… is to evaluate the efficacy and safety of apatinib in patients with advanced NSCLC after first-…
Clinical observation of apatinib mesylate in treatment of advanced non-small cell lung cancer…
Clinical observation of apatinib mesylate in treatment of advanced non-small cell lung cancer…
阿帕替尼一线治疗晚期肝癌疗效观察
柯少波， 汪晶， 邱虎， 蔡高科， 龚毅， 陈永顺 - 肿瘤防治研究, 2021 - zlfzyj.com
… Progress of Apatinib in Treatment of Non-small Cell Lung Cancer 肿瘤防治研究. 2018, …
Efficacy and safety of apatinib in treatment of elderly patients with advanced hepatocellular cancer…
Efficacy and safety of apatinib in treatment of elderly patients with advanced hepatocellular cancer…
[PDF][PDF] 阿帕替尼二线及二线以上治疗晚期肺癌26 例
陈玲娟， 伍钢， 董晓荣， 张瑞光 - 医药导报, 2018 - yydbzz.com
… apatinib treatment improved PFS with an acceptable safety profile in … efficacy and safety
of bevacizumab in the systemic treatment of patients with advanced non-small cell lung cancer. …
of bevacizumab in the systemic treatment of patients with advanced non-small cell lung cancer. …
[HTML][HTML] 阿帕替尼在二线以上小细胞肺癌中的临床应用
畅婕， 高宏祥， 杨拴盈， 杜建飞 - 中华肺部疾病杂志(电子 …, 2020 - zhfbjbzz.cma-cmc.com.cn
… Efficacy and survival analysis of apatinib in treatment of beyond second-line small cell lung
cancer… analysis of apatinib in the patients with advanced small cell lung cancer (SCLC) after …
cancer… analysis of apatinib in the patients with advanced small cell lung cancer (SCLC) after …
阿帕替尼后线治疗晚期食管鳞癌患者的疗效及安全性
侯继院， 祁佩红， 王海霞， 龚哲， 单国用 - 肿瘤防治研究, 2022 - zlfzyj.com
… investigate the efficacy and safety of apatinib monotherapy as subsequent-line therapy on
patients with advanced ESCC. Methods We included 56 patients with advanced ESCC who …
patients with advanced ESCC. Methods We included 56 patients with advanced ESCC who …